2nd Quarter - Report — EMD SERONO, INC. for EMD SERONO INC (2026)

Firm

EMD SERONO, INC.

Client

EMD SERONO INC

Income

—

Expenses

$700,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

General discussions related to Biopharmaceutical innovation and patent policy issues

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Discussions related to tariffs and trade - Section 232 and Section 301 Discussions related to clinical minerals access

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
DAVID NICHOLS	—
MARY BETH SPENCER	—

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; State, Dept of (DOS); SENATE

P.L. 119-21 (H.R. 1): One Big Beautiful Bill Act; provisions related to Title VII, Subtitle B H.R. 946: Orphan CURES Act; all provisions H.R. 2214: DRUG Act; all provisions H.R. 4317: PBM Reform Act of 2025; all provisions H.R. 6703: Lower Health Care Premiums for All Americans Act; provisions related to Pharmacy Benefit Management (PBM) S. 864: HELP Copays Act; all provisions S. 882: Patients Before Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX S. 1862: Orphan CURES Act; all provisions S. 3345: PBM Price Transparency and Accountability Act; all provisions Executive Order: Expanding Access to In Vitro Fertilization; all provisions of the order Executive Order: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; all provisions of the order General discussions related to Pharmacy Benefit Manager (PBM) policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 946 (119th), H.R. 2214 (119th), H.R. 4317 (119th), S. 1862 (119th), S. 3345 (119th), H.R. 6703 (119th), S. 882 (119th), S. 864 (119th), S. 891 (119th), H.R. 1 (119th)

Medicare/Medicaid MMM

P.L. 119-21 (H.R. 1): One Big Beautiful Bill Act; relating to Title VII, Subtitle B H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.; all provisions S. 832: EPIC Act of 2025; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX General discussions related to Drug cost and pricing policy issues

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th), H.R. 1492 (119th), S. 891 (119th), S. 832 (119th)

Pharmacy PHA

H.R.5256: 340B ACCESS Act; all provisions General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues General discussions related to 340B Drug Pricing Program policy issues

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5256 (119th)

Veterans VET

H.R. 220: Veterans Infertility Treatment Act of 2025; all provisions

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 220 (119th)

Defense DEF

H.R. 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care H.R. 6797: Bipartisan IVF for Military Families Act; all provisions H.R. 8800: National Defense Authorization Act for Fiscal Year 2027; provisions related to Military access to infertility care S. 1071: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care Discussions related to Military access to infertility care

Lobbyist	Covered position, as disclosed
THOMAS BORCK	—
MALLORI ANNE MERANDINO	—
TERRI STEWART	—

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 6797 (119th), S. 2296 (119th), H.R. 3838 (119th), H.R. 8800 (119th), S. 1071 (119th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

Entity	Country	Principal place of business	Ownership	Contribution declared
MERCK PTE. LTD.	Singapore	Singapore	—	$10,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.